Neurogastrx
neurogastrx.com
Actively hiring
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$80M
2 rounds on record
Latest round
$60M
Venture round · Jun 2021 · 5 yr ago
Team
7
US Form 5500 (plan participants) · Dec 2024
Backers
2
OrbiMed, venBio Partners
The money's age
Long since its last round
63 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 25, 2021
Raised a round Venture round $60M · SEC Form D
Jun 18, 2021
Raised a round Venture round $20M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2021 | $60M | — | SEC Form D |
| Venture round | Jun 2021 | $20M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Neurogastrx, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Cyril De ColleExecutive Officer, DirectorSEC Form D
James DetoreExecutive OfficerSEC Form D
Paul RogersExecutive OfficerSEC Form D
James O'maraExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed 
venBio Partners Similar startupsby what they do, their industry and backers
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…
Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for…
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
Overview
Neurogastrx, Inc.. Thank you for visiting the website for Neurogastrx, Inc. ("Company"), a privately held, late clinical-stage biopharmaceutical company formerly headquartered in Woburn, MA.
News
Report
Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek
Nausea and Vomiting Are the Most Frequent Reasons for Discontinuing GLP-1 Therapies, Significantly Impacting Adherence, Titration and Preventing A...
Read more
Report
Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek
Nausea and Vomiting Are the Most Frequent Reasons for Discontinuing GLP-1 Therapies, Significantly Impacting Adherence, Titration and Preventing Achievement of Proven Long-Term Benefits WOBURN, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Neurogastrx, Inc., t
Read more
Report
Neurogastrx Announces Positive Proof-of-Concept Data for Investigational Drug NG101 in Reducing Nausea and Vomiting Associated with the Administration of GLP-1 Agonist Medication
media438118
Read more
Report
Neurogastrx Announces Positive Proof-of-Concept Data for Investigational Drug NG101 in Reducing Nausea and Vomiting Associated with the Administration of GLP-1 Agonist Medication
NG101 Significantly Reduced Incidence of Nausea by 40% and Frequency of Vomiting by 56% without Changing the Safety Profile of the GLP-1 AgonistWOBURN, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Neurogastrx, Inc. today announced positive topline results fro
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Cyril De Colle
Executive Officer, Director
James Detore
Executive Officer
Paul Rogers
Executive Officer
James O'mara
Executive Officer, Director
Aaron Royston
Director
David Allison
Director
Klaus Vettinger
Director
Kevin Koch
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Woburn
United States
HQ
200-500 est. staff